Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2

[1]  Junjiang Fu,et al.  Impact of TMPRSS2 Expression, Mutation Prognostics, and Small Molecule (CD, AD, TQ, and TQFL12) Inhibition on Pan-Cancer Tumors and Susceptibility to SARS-CoV-2 , 2022, Molecules.

[2]  Junjiang Fu,et al.  The Correlation Between Immune Invasion and SARS-COV-2 Entry Protein ADAM17 in Cancer Patients by Bioinformatic Analysis , 2022, Frontiers in Immunology.

[3]  Xuepeng Wang,et al.  SARS-CoV-2 pseudovirus enters the host cells through spike protein-CD147 in an Arf6-dependent manner , 2022, Emerging microbes & infections.

[4]  A. Mugan,et al.  Computational Modeling of T Cell Hypersensitivity during Coronavirus Infections Leading to Autoimmunity and Lethality , 2022, Computational and mathematical methods in medicine.

[5]  Junjiang Fu,et al.  COVID-19 receptor and malignant cancers: Association of CTSL expression with susceptibility to SARS-CoV-2 , 2022, International journal of biological sciences.

[6]  H. Bian,et al.  Active demethylation upregulates CD147 expression promoting non-small cell lung cancer invasion and metastasis , 2022, Oncogene.

[7]  Guizhen Wu,et al.  CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma , 2021, Signal Transduction and Targeted Therapy.

[8]  Junjiang Fu,et al.  COVID-19 disease and malignant cancers: The impact for the furin gene expression in susceptibility to SARS-CoV-2 , 2021, International journal of biological sciences.

[9]  M. Clerici,et al.  SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2 , 2021, Cells.

[10]  André F. Rendeiro,et al.  A molecular single-cell lung atlas of lethal COVID-19 , 2021, Nature.

[11]  Jingliang Cheng,et al.  Prostate adenocarcinoma and COVID‐19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS‐CoV‐2 , 2021, Journal of cellular and molecular medicine.

[12]  Junjiang Fu,et al.  Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19 , 2021, International journal of biological sciences.

[13]  D. Baralle,et al.  A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection , 2021, Nature Genetics.

[14]  A. Verma,et al.  Repurposing potential of FDA‐approved and investigational drugs for COVID‐19 targeting SARS‐CoV‐2 spike and main protease and validation by machine learning algorithm , 2020, Chemical biology & drug design.

[15]  Zhaohui Zheng,et al.  CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells , 2020, Signal Transduction and Targeted Therapy.

[16]  A. Pareek,et al.  Clinical Characteristics and Outcomes in Patients with COVID-19 and Cancer: a Systematic Review and Meta-analysis , 2020, Clinical Oncology.

[17]  Ting Guo,et al.  CD147 regulates antitumor CD8+ T-cell responses to facilitate tumor-immune escape , 2020, Cellular & Molecular Immunology.

[18]  Kwok-Kin Wong,et al.  Clinical Characteristics and Outcomes of COVID-19–Infected Cancer Patients: A Systematic Review and Meta-Analysis , 2020, Journal of the National Cancer Institute.

[19]  M. Shahhoseini,et al.  COVID-19 Mediated by Basigin Can Affect Male and Female Fertility , 2020, International journal of fertility & sterility.

[20]  W. Zong,et al.  Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma , 2020, Nature Communications.

[21]  Gavin J. Wright,et al.  No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor , 2020, bioRxiv.

[22]  Jun Yu Li,et al.  Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study , 2020, The Lancet Oncology.

[23]  H. Randeva,et al.  Pan-cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS-CoV-2 infection leading to COVID-19 , 2020, International journal of oncology.

[24]  Junjiang Fu,et al.  Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19 , 2020, Molecular Biology Reports.

[25]  Shao-bo Shi,et al.  Clinical characteristics and outcomes of cancer patients with COVID‐19 , 2020, Journal of medical virology.

[26]  H. Ulrich,et al.  CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement , 2020, Stem Cell Reviews and Reports.

[27]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[28]  B. Canard,et al.  The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade , 2020, Antiviral Research.

[29]  P. Horby,et al.  A novel coronavirus outbreak of global health concern , 2020, The Lancet.

[30]  Tieliu Shi,et al.  DNMIVD: DNA methylation interactive visualization database , 2019, Nucleic Acids Res..

[31]  J. Luban.  SARS-CoV-2 , 2020 .

[32]  Jingliang Cheng,et al.  Cordycepin Inhibits Drug-resistance Non-small Cell Lung Cancer Progression by Activating AMPK Signaling Pathway. , 2019, Pharmacological research.

[33]  Tieliu Shi,et al.  Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis , 2019, Epigenetics.

[34]  C. Lindskog,et al.  A pathology atlas of the human cancer transcriptome , 2017, Science.

[35]  Devin P. Sullivan,et al.  A subcellular map of the human proteome , 2017, Science.

[36]  Cheng Li,et al.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..

[37]  Huajian Gu,et al.  CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis , 2016, Scientific Reports.

[38]  Jingliang Cheng,et al.  Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein , 2016, Scientific Reports.

[39]  Wei Li,et al.  EMMPRIN-mediated induction of uterine and vascular matrix metalloproteinases during pregnancy and in response to estrogen and progesterone. , 2013, Biochemical pharmacology.

[40]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[41]  Clement T Y Chan,et al.  Identification of N6,N6-Dimethyladenosine in Transfer RNA from Mycobacterium bovis Bacille Calmette-Guérin , 2011, Molecules.

[42]  J. Xing,et al.  Function of HAb18G/CD147 in Invasion of Host Cells by Severe Acute Respiratory Syndrome Coronavirus , 2005, The Journal of infectious diseases.

[43]  H. Macdonald,et al.  A Role for CD147 in Thymic Development , 2002, The Journal of Immunology.

[44]  M. Bukrinsky,et al.  CD147 is a signaling receptor for cyclophilin B. , 2001, Biochemical and biophysical research communications.

[45]  M. Bukrinsky,et al.  CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Mizutani,et al.  Female sterility in mice lacking the basigin gene, which encodes a transmembrane glycoprotein belonging to the immunoglobulin superfamily , 1998, FEBS letters.

[47]  K. Yamamura,et al.  A null mutation in basigin, an immunoglobulin superfamily member, indicates its important roles in peri-implantation development and spermatogenesis. , 1998, Developmental biology.

[48]  T. Hasegawa,et al.  Abnormalities of sensory and memory functions in mice lacking Bsg gene. , 1997, Biochemical and biophysical research communications.

[49]  A. Kuwano,et al.  Mapping basigin (BSG), a member of the immunoglobulin superfamily, to 19p13.3. , 1993, Cytogenetics and cell genetics.

[50]  D. Keast.  Immunosuppression and cancer. , 1969, Lancet.